肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
临床试验招募
登录/注册
VIP特权
广告
广告加载中...

文章:

早期胃癌的内镜与外科治疗:内镜医师视角下的治疗决策灰色地带

Endoscopic and Surgical Treatment in Early Gastric Cancer: The Gray Zone in Treatment Decision-Making from the Perspectives of Endoscopists

原文发布日期:10 February 2025

DOI: 10.3390/cancers17040602

类型: Article

开放获取: 是

 

英文摘要:

To treat early gastric cancer, one must choose between endoscopic treatment and surgical treatment. Endoscopic treatment has been developing significantly since the late 1990s and has made great progress up to the present. However, many patients with early gastric cancer still undergo unnecessary surgery or endoscopic procedures. This is due to the existence of a “gray zone” of ambiguities between endoscopic and surgical treatment. These ambiguities arise because the important factors in determining the treatment for early gastric cancer can only be fully understood after endoscopic or surgical resection or because of discrepancies between the factors identifiable before treatment and those identifiable after treatment. This article aims to explore these ambiguous factors and discuss methods and efforts to reduce them.

 

摘要翻译: 

治疗早期胃癌时,必须在内镜治疗与手术治疗之间做出选择。自20世纪90年代末以来,内镜治疗技术取得显著发展,至今已实现重大突破。然而,目前仍有大量早期胃癌患者接受了不必要的手术或内镜治疗。这种现象源于内镜治疗与手术治疗之间存在一个充满不确定性的"灰色地带"。这种不确定性主要源于两方面:一是决定早期胃癌治疗方案的关键因素往往只能在完成内镜或手术切除后才能完全明确;二是治疗前可识别的因素与治疗后实际发现的因素之间存在差异。本文旨在探讨这些不确定因素,并就如何减少这些因素的方法与努力方向展开讨论。

 

原文链接:

Endoscopic and Surgical Treatment in Early Gastric Cancer: The Gray Zone in Treatment Decision-Making from the Perspectives of Endoscopists

广告
广告加载中...